Form 4: Teladoc Health President Sells Shares
Insider Transaction (Form 4)
Kelly Bliss, President, U.S. Group Health of Teladoc Health, Inc., sold 7,357 shares of common stock on September 1, 2026 for $6.30 per share.
Summary
- Option exercise/conversion: acquired 4,859 Common Stock on September 1, 2026; holds 89,737 after (Direct).
- Option exercise/conversion: acquired 9,152 Common Stock on September 1, 2026; holds 98,889 after (Direct).
- Option exercise/conversion: acquired 1,300 Common Stock on September 1, 2026; holds 100,189 after (Direct).
- Open-market sale: disposed of 7,357 Common Stock at $6.30 ($46,356) on September 2, 2026; holds 92,832 after (Direct).
- Option exercise/conversion: disposed of 4,859 Restricted Stock Units on September 1, 2026; holds 9,718 after (Direct).
- Option exercise/conversion: disposed of 9,152 Restricted Stock Units on September 1, 2026; holds 54,918 after (Direct).
- Option exercise/conversion: disposed of 1,300 Performance Stock Units on September 1, 2026; holds 7,798 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $46,356 of stock on the open market.
Insider Transactions
Kelly Bliss — Officer (President, U.S. Group Health)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Option exercise/conversion | Common Stock | 4,859 | — | — | 89,737 |
| 2026-09-01 | Option exercise/conversion | Common Stock | 9,152 | — | — | 98,889 |
| 2026-09-01 | Option exercise/conversion | Common Stock | 1,300 | — | — | 100,189 |
| 2026-09-02 | Open-market sale | Common Stock | 7,357 | $6 | $46.4K | 92,832 |
| 2026-09-01 | Option exercise/conversion | Restricted Stock Units | 4,859 | — | — | 9,718 |
| 2026-09-01 | Option exercise/conversion | Restricted Stock Units | 9,152 | — | — | 54,918 |
| 2026-09-01 | Option exercise/conversion | Performance Stock Units | 1,300 | — | — | 7,798 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Option exercise/conversion (4,859 shares) |
| 2026-09-01 | Option exercise/conversion (9,152 shares) |
| 2026-09-01 | Option exercise/conversion (1,300 shares) |
| 2026-09-02 | Open-market sale (7,357 shares) |
| 2026-09-01 | Option exercise/conversion (4,859 shares) |
| 2026-09-01 | Option exercise/conversion (9,152 shares) |
| 2026-09-01 | Option exercise/conversion (1,300 shares) |
Keywords
insider transaction, Form 4, TDOC, Teladoc Health, Inc., bearish, Kelly Bliss
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.